Results
|
|
1.
|
The spectrum of 124I uptake in the lacrimal gland and nasolacrimal sac/duct on PET/CT imaging. MedStar authors:
- Burman, Kenneth D
- Garcia, Carlos
- Kulkarni, Kanchan
- Plyku, Donika
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
Year: 2021
Citation: - Nuclear Medicine Communications. 42(3):292-299, 2021 Mar 01.
Institution: - MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
Medline publication type:
All authors: - Burman KD, Garcia C, Kulkarni K, Plyku D, Van Nostrand D, Wartofsky L, Wu D
|
|
|
2.
|
<sup>18</sup>F-FDG-PET SUV AS A PROGNOSTIC MARKER OF INCREASING SIZE IN THYROID CANCER TUMORS. MedStar authors:
- Bikas, Athanasios
- Burman, Kenneth D
- Desale, Sameer
- Garcia, Carlos
- Singh, Ishita
- Wartofsky, Leonard
Year: 2017
Citation: - Endocrine Practice. 23(2):182-189, 2017 Feb
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
Medline publication type:
All authors: - Bikas A, Burman KD, Desale S, Garcia CA, Singh I, Wartofsky L
|
|
|
3.
|
|
|
|
4.
|
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. MedStar authors:
- Atkins, Francis
- Garcia, Carlos
- Van Nostrand, Douglas
Year: 2017
Citation: - Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
Medline publication type:
All authors: - Atkins F, Garcia C, Hobbs RF, Huang K, Plyku D, Sgouros G, Van Nostrand D
|
|
|
5.
|
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET.[Erratum appears in J Nucl Med. 2012 May;53(5):830] MedStar authors:
- Atkins, Frank B
- Burman, Kenneth D
- Chennupati, Shyam P
- Kharazi, Pejman
- Khorjekar, Gauri R
- Mete, Mihriye
- Moreau, Shari
- O'Neil, Jeff
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2012
Citation: - Journal of Nuclear Medicine. 53(3):359-62, 2012 Mar.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Atkins FB, Burman KD, Chennupati SP, Kharazi P, Khorjekar GR, Mete M, Moreau S, O'Neil J, Van Nostrand D, Wartofsky L
|
|
|
6.
|
CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease. MedStar authors:
Year: 2019
Citation: - Endocrine. 65(1):155-165, 2019 07.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Benzo S, Boyle J, Chatain GP, Chittiboina P, Dieckman W, Edwards N, Hayes CP, Herscovitch P, Lodish MB, Lonser RR, Maric D, Millo C, Nieman LK, Patronas NJ, Ray Chaudhury A, Scott G, Sharma S, Smirniotopoulos J, Stratakis CA
|
|
|
7.
|
Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study. MedStar authors:
Year: 2020
Citation: - European Journal of Endocrinology. 183(4):453-462, 2020 Oct.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Antke C, Arlt W, Beuschlein F, Casanovas O, Chortis V, Fassnacht M, Gattermann N, Germing U, Gimm O, Haas R, Haase M, Habra M, Ho ATN, Kanji A, Kondakci M, Laurent C, Limvorapitak W, Majidi F, Martino S, Petit JM, Ronchi CL, Rudelius M, Salvatori R, Schott M, Spyroglou A, Villa D, Wahlin BE
|
